Rick D. Scruggs

Rick D. Scruggs appears in our data through filings on Salix Pharmaceuticals Ltd shares, published by SEC (Form 4). Between 1 July 2011 and 1 April 2015, the trades on record add up to 21 filings.

No open-market purchase appears, only 6 sales worth €1.6M. Outside the open market, there are 13 share grants. Since January 2015: no purchases and 1 sale on the market.

The newest entry dates from 3 April 2015: a transaction of €7.7M, in Salix Pharmaceuticals Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.